aluates Reports

$ 0.0

Automative

Global Small Nucleic Acid Drug Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-0G13004

Global Small Nucleic Acid Drug Market Research Report 2022

BUY CHAPTERS

Global Small Nucleic Acid Drug Market Research Report 2025

Code: QYRE-Auto-0G13004

Report

March 2025

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ionis Pharmaceuticals

Sarepta Therapeutics

Biogen

Nippon Shinyaku

Alnylam

SOBI

Novartis

Jazz Pharmaceuticals

CureVac

Regulus Therapeutics

ProQR

Secarna

Mina Therapeutics

Sylentis

Arrowhead

Silence Therapeutics

Astrazeneca plc

Novo Nordisk

Astellas Pharma

Geron Corporation

Small Nucleic Acid Drug Market Size

The global market for Small Nucleic Acid Drug was valued at US$ 5909 million in the year 2024 and is projected to reach a revised size of US$ 19370 million by 2031, growing at a CAGR of 18.8% during the forecast period.

Small Nucleic Acid Drug Market

Small nucleic acid drugs, such as siRNA, ASO, miRNA, Aptamer, etc., function based on the RNAi process and offer various advantages, including unlimited target drug ability, high specificity, long half-life, faster and more efficient design, development and production process.

Small nucleic acid drugs, composed of nucleotides, represent a novel class of pharmaceuticals that differ significantly from conventional small molecule and antibody-based therapeutics. These agents function by selectively targeting specific genes or their corresponding messenger RNAs (mRNAs), further modulating gene expression and regulating translation-related processes. Prominent examples within this category include antisense oligonucleotides (ASO), small interfering RNAs (siRNAs), microRNAs (miRNAs), and aptamers.

The Small Nucleic Acid Drug Market is driven by the transformative potential of small nucleic acids, including microRNA, aptamers, and small interfering RNA (siRNA), in treating a wide spectrum of diseases, from genetic disorders to cancer and viral infections. These therapies harness the power of small nucleic acids to modulate gene expression, inhibit specific targets, and diagnose diseases, offering a precise and personalized approach to treatment. As genomics and RNA-based research advance, and precision medicine gains prominence, the demand for small nucleic acid drugs continues to surge. Innovations in nucleic acid design, delivery systems, and gene-editing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to overcome hurdles related to safe and efficient drug delivery, minimize off-target effects, ensure long-term safety and efficacy, and navigate complex regulatory pathways. Addressing delivery challenges, optimizing pharmacokinetics, and managing development costs are ongoing hurdles. Additionally, the market faces competition from traditional therapeutic approaches, necessitating continuous research and development efforts to unlock the full therapeutic potential of small nucleic acid drugs. Striking a balance between providing safe, effective, and accessible small nucleic acid therapies while addressing scientific and regulatory challenges is paramount for the continued growth of the Small Nucleic Acid Drug Market.

North America is the largest consumption place, with a consumption market share nearly 55.11% in 2023. Following North Americas, Europe is the second largest consumption place with the consumption market share of 34.29%.

The global key companies of Small Nucleic Acid Drug include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, Jazz Pharmaceuticals, etc. In 2023, the global top five players had a share approximately 94.96% in terms of revenue.

A key trend in the small nucleic acid drugs market is the development of advanced delivery systems to improve the stability and cellular uptake of these therapies. Lipid nanoparticles (LNPs), polymer-based carriers, and exosome-based delivery platforms are gaining traction due to their ability to protect nucleic acids from degradation and enhance target specificity. These innovations are crucial for overcoming the delivery challenges associated with small nucleic acid drugs, particularly for therapies targeting difficult-to-reach tissues such as the brain or tumors.

While small nucleic acid drugs initially focused on rare genetic disorders, there is a growing trend toward applying these therapies to more common diseases, such as cardiovascular conditions, autoimmune disorders, and metabolic diseases. This shift is driven by advancements in gene-editing tools and RNA interference technology, which expand the potential therapeutic targets. The broadening scope of indications is expected to significantly increase the market size and attract more pharmaceutical companies into this space.

This report aims to provide a comprehensive presentation of the global market for Small Nucleic Acid Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Nucleic Acid Drug.

The Small Nucleic Acid Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Nucleic Acid Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Small Nucleic Acid Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Small Nucleic Acid Drug Market Report

Report Metric	Details
Report Name	Small Nucleic Acid Drug Market
Accounted market size in year	US$ 5909 million
Forecasted market size in 2031	US$ 19370 million
CAGR	18.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antisense Oligonucleotides (ASO) siRNA Other
Segment by Application	Neuromuscular Diseases hATTR Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, Jazz Pharmaceuticals, AstraZeneca, Novo Nordisk, Astellas Pharma, Geron Corporation, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Nucleic Acid Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Small Nucleic Acid Drug Market growing?

Ans: The Small Nucleic Acid Drug Market witnessing a CAGR of 18.8% during the forecast period 2025-2031.

What is the Small Nucleic Acid Drug Market size in 2031?

Ans: The Small Nucleic Acid Drug Market size in 2031 will be US$ 19370 million.

What is the Small Nucleic Acid Drug Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 55.11% in 2023.

What is the market share of major companies in Small Nucleic Acid Drug Market?

Ans: In 2023, the global top five players had a share approximately 94.96% in terms of revenue.

Who are the main players in the Small Nucleic Acid Drug Market report?

Ans: The main players in the Small Nucleic Acid Drug Market are Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, Jazz Pharmaceuticals, AstraZeneca, Novo Nordisk, Astellas Pharma, Geron Corporation, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics

What are the Application segmentation covered in the Small Nucleic Acid Drug Market report?

Ans: The Applications covered in the Small Nucleic Acid Drug Market report are Neuromuscular Diseases, hATTR, Other

What are the Type segmentation covered in the Small Nucleic Acid Drug Market report?

Ans: The Types covered in the Small Nucleic Acid Drug Market report are Antisense Oligonucleotides (ASO), siRNA, Other

Recommended Reports

Nucleic Acid Therapeutics

RNA-Based Therapeutics

Oligonucleotide Drug Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Small Nucleic Acid Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antisense Oligonucleotides (ASO)

1.2.3 siRNA

1.2.4 Other

1.3 Market by Application

1.3.1 Global Small Nucleic Acid Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Neuromuscular Diseases

1.3.3 hATTR

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Small Nucleic Acid Drug Market Perspective (2020-2031)

2.2 Global Small Nucleic Acid Drug Growth Trends by Region

2.2.1 Global Small Nucleic Acid Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Small Nucleic Acid Drug Historic Market Size by Region (2020-2025)

2.2.3 Small Nucleic Acid Drug Forecasted Market Size by Region (2026-2031)

2.3 Small Nucleic Acid Drug Market Dynamics

2.3.1 Small Nucleic Acid Drug Industry Trends

2.3.2 Small Nucleic Acid Drug Market Drivers

2.3.3 Small Nucleic Acid Drug Market Challenges

2.3.4 Small Nucleic Acid Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Small Nucleic Acid Drug Players by Revenue

3.1.1 Global Top Small Nucleic Acid Drug Players by Revenue (2020-2025)

3.1.2 Global Small Nucleic Acid Drug Revenue Market Share by Players (2020-2025)

3.2 Global Small Nucleic Acid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Small Nucleic Acid Drug Revenue

3.4 Global Small Nucleic Acid Drug Market Concentration Ratio

3.4.1 Global Small Nucleic Acid Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Small Nucleic Acid Drug Revenue in 2024

3.5 Global Key Players of Small Nucleic Acid Drug Head office and Area Served

3.6 Global Key Players of Small Nucleic Acid Drug, Product and Application

3.7 Global Key Players of Small Nucleic Acid Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Small Nucleic Acid Drug Breakdown Data by Type

4.1 Global Small Nucleic Acid Drug Historic Market Size by Type (2020-2025)

4.2 Global Small Nucleic Acid Drug Forecasted Market Size by Type (2026-2031)

5 Small Nucleic Acid Drug Breakdown Data by Application

5.1 Global Small Nucleic Acid Drug Historic Market Size by Application (2020-2025)

5.2 Global Small Nucleic Acid Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Small Nucleic Acid Drug Market Size (2020-2031)

6.2 North America Small Nucleic Acid Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Small Nucleic Acid Drug Market Size by Country (2020-2025)

6.4 North America Small Nucleic Acid Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Small Nucleic Acid Drug Market Size (2020-2031)

7.2 Europe Small Nucleic Acid Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Small Nucleic Acid Drug Market Size by Country (2020-2025)

7.4 Europe Small Nucleic Acid Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Small Nucleic Acid Drug Market Size (2020-2031)

8.2 Asia-Pacific Small Nucleic Acid Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Small Nucleic Acid Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Small Nucleic Acid Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Small Nucleic Acid Drug Market Size (2020-2031)

9.2 Latin America Small Nucleic Acid Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Small Nucleic Acid Drug Market Size by Country (2020-2025)

9.4 Latin America Small Nucleic Acid Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Small Nucleic Acid Drug Market Size (2020-2031)

10.2 Middle East & Africa Small Nucleic Acid Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Small Nucleic Acid Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Small Nucleic Acid Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sarepta Therapeutics

11.1.1 Sarepta Therapeutics Company Details

11.1.2 Sarepta Therapeutics Business Overview

11.1.3 Sarepta Therapeutics Small Nucleic Acid Drug Introduction

11.1.4 Sarepta Therapeutics Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.1.5 Sarepta Therapeutics Recent Development

11.2 Ionis Pharmaceuticals

11.2.1 Ionis Pharmaceuticals Company Details

11.2.2 Ionis Pharmaceuticals Business Overview

11.2.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Introduction

11.2.4 Ionis Pharmaceuticals Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.2.5 Ionis Pharmaceuticals Recent Development

11.3 Alnylam

11.3.1 Alnylam Company Details

11.3.2 Alnylam Business Overview

11.3.3 Alnylam Small Nucleic Acid Drug Introduction

11.3.4 Alnylam Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.3.5 Alnylam Recent Development

11.4 Biogen

11.4.1 Biogen Company Details

11.4.2 Biogen Business Overview

11.4.3 Biogen Small Nucleic Acid Drug Introduction

11.4.4 Biogen Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.4.5 Biogen Recent Development

11.5 Nippon Shinyaku

11.5.1 Nippon Shinyaku Company Details

11.5.2 Nippon Shinyaku Business Overview

11.5.3 Nippon Shinyaku Small Nucleic Acid Drug Introduction

11.5.4 Nippon Shinyaku Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.5.5 Nippon Shinyaku Recent Development

11.6 Sobi

11.6.1 Sobi Company Details

11.6.2 Sobi Business Overview

11.6.3 Sobi Small Nucleic Acid Drug Introduction

11.6.4 Sobi Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.6.5 Sobi Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Small Nucleic Acid Drug Introduction

11.7.4 Novartis Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 Jazz Pharmaceuticals

11.8.1 Jazz Pharmaceuticals Company Details

11.8.2 Jazz Pharmaceuticals Business Overview

11.8.3 Jazz Pharmaceuticals Small Nucleic Acid Drug Introduction

11.8.4 Jazz Pharmaceuticals Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.8.5 Jazz Pharmaceuticals Recent Development

11.9 AstraZeneca

11.9.1 AstraZeneca Company Details

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Small Nucleic Acid Drug Introduction

11.9.4 AstraZeneca Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.9.5 AstraZeneca Recent Development

11.10 Novo Nordisk

11.10.1 Novo Nordisk Company Details

11.10.2 Novo Nordisk Business Overview

11.10.3 Novo Nordisk Small Nucleic Acid Drug Introduction

11.10.4 Novo Nordisk Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.10.5 Novo Nordisk Recent Development

11.11 Astellas Pharma

11.11.1 Astellas Pharma Company Details

11.11.2 Astellas Pharma Business Overview

11.11.3 Astellas Pharma Small Nucleic Acid Drug Introduction

11.11.4 Astellas Pharma Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.11.5 Astellas Pharma Recent Development

11.12 Geron Corporation

11.12.1 Geron Corporation Company Details

11.12.2 Geron Corporation Business Overview

11.12.3 Geron Corporation Small Nucleic Acid Drug Introduction

11.12.4 Geron Corporation Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.12.5 Geron Corporation Recent Development

11.13 CureVac

11.13.1 CureVac Company Details

11.13.2 CureVac Business Overview

11.13.3 CureVac Small Nucleic Acid Drug Introduction

11.13.4 CureVac Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.13.5 CureVac Recent Development

11.14 Regulus Therapeutics

11.14.1 Regulus Therapeutics Company Details

11.14.2 Regulus Therapeutics Business Overview

11.14.3 Regulus Therapeutics Small Nucleic Acid Drug Introduction

11.14.4 Regulus Therapeutics Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.14.5 Regulus Therapeutics Recent Development

11.15 ProQR

11.15.1 ProQR Company Details

11.15.2 ProQR Business Overview

11.15.3 ProQR Small Nucleic Acid Drug Introduction

11.15.4 ProQR Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.15.5 ProQR Recent Development

11.16 Secarna

11.16.1 Secarna Company Details

11.16.2 Secarna Business Overview

11.16.3 Secarna Small Nucleic Acid Drug Introduction

11.16.4 Secarna Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.16.5 Secarna Recent Development

11.17 MiNA Therapeutics

11.17.1 MiNA Therapeutics Company Details

11.17.2 MiNA Therapeutics Business Overview

11.17.3 MiNA Therapeutics Small Nucleic Acid Drug Introduction

11.17.4 MiNA Therapeutics Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.17.5 MiNA Therapeutics Recent Development

11.18 Sylentis

11.18.1 Sylentis Company Details

11.18.2 Sylentis Business Overview

11.18.3 Sylentis Small Nucleic Acid Drug Introduction

11.18.4 Sylentis Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.18.5 Sylentis Recent Development

11.19 Arrowhead

11.19.1 Arrowhead Company Details

11.19.2 Arrowhead Business Overview

11.19.3 Arrowhead Small Nucleic Acid Drug Introduction

11.19.4 Arrowhead Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.19.5 Arrowhead Recent Development

11.20 Silence Therapeutics

11.20.1 Silence Therapeutics Company Details

11.20.2 Silence Therapeutics Business Overview

11.20.3 Silence Therapeutics Small Nucleic Acid Drug Introduction

11.20.4 Silence Therapeutics Revenue in Small Nucleic Acid Drug Business (2020-2025)

11.20.5 Silence Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ionis Pharmaceuticals

Sarepta Therapeutics

Biogen

Nippon Shinyaku

Alnylam

SOBI

Novartis

Jazz Pharmaceuticals

CureVac

Regulus Therapeutics

ProQR

Secarna

Mina Therapeutics

Sylentis

Arrowhead

Silence Therapeutics

Astrazeneca plc

Novo Nordisk

Astellas Pharma

Geron Corporation

List of Tables

Table 1. Global Small Nucleic Acid Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antisense Oligonucleotides (ASO)

Table 3. Key Players of siRNA

Table 4. Key Players of Other

Table 5. Global Small Nucleic Acid Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Small Nucleic Acid Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Small Nucleic Acid Drug Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Small Nucleic Acid Drug Market Share by Region (2020-2025)

Table 9. Global Small Nucleic Acid Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Small Nucleic Acid Drug Market Share by Region (2026-2031)

Table 11. Small Nucleic Acid Drug Market Trends

Table 12. Small Nucleic Acid Drug Market Drivers

Table 13. Small Nucleic Acid Drug Market Challenges

Table 14. Small Nucleic Acid Drug Market Restraints

Table 15. Global Small Nucleic Acid Drug Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Small Nucleic Acid Drug Market Share by Players (2020-2025)

Table 17. Global Top Small Nucleic Acid Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Nucleic Acid Drug as of 2024)

Table 18. Ranking of Global Top Small Nucleic Acid Drug Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Small Nucleic Acid Drug Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Small Nucleic Acid Drug, Headquarters and Area Served

Table 21. Global Key Players of Small Nucleic Acid Drug, Product and Application

Table 22. Global Key Players of Small Nucleic Acid Drug, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Small Nucleic Acid Drug Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Small Nucleic Acid Drug Revenue Market Share by Type (2020-2025)

Table 26. Global Small Nucleic Acid Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Small Nucleic Acid Drug Revenue Market Share by Type (2026-2031)

Table 28. Global Small Nucleic Acid Drug Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Small Nucleic Acid Drug Revenue Market Share by Application (2020-2025)

Table 30. Global Small Nucleic Acid Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Small Nucleic Acid Drug Revenue Market Share by Application (2026-2031)

Table 32. North America Small Nucleic Acid Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Small Nucleic Acid Drug Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Small Nucleic Acid Drug Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Small Nucleic Acid Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Small Nucleic Acid Drug Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Small Nucleic Acid Drug Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Small Nucleic Acid Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Small Nucleic Acid Drug Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Small Nucleic Acid Drug Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Small Nucleic Acid Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Small Nucleic Acid Drug Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Small Nucleic Acid Drug Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Small Nucleic Acid Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Small Nucleic Acid Drug Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Small Nucleic Acid Drug Market Size by Country (2026-2031) & (US$ Million)

Table 47. Sarepta Therapeutics Company Details

Table 48. Sarepta Therapeutics Business Overview

Table 49. Sarepta Therapeutics Small Nucleic Acid Drug Product

Table 50. Sarepta Therapeutics Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 51. Sarepta Therapeutics Recent Development

Table 52. Ionis Pharmaceuticals Company Details

Table 53. Ionis Pharmaceuticals Business Overview

Table 54. Ionis Pharmaceuticals Small Nucleic Acid Drug Product

Table 55. Ionis Pharmaceuticals Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 56. Ionis Pharmaceuticals Recent Development

Table 57. Alnylam Company Details

Table 58. Alnylam Business Overview

Table 59. Alnylam Small Nucleic Acid Drug Product

Table 60. Alnylam Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 61. Alnylam Recent Development

Table 62. Biogen Company Details

Table 63. Biogen Business Overview

Table 64. Biogen Small Nucleic Acid Drug Product

Table 65. Biogen Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 66. Biogen Recent Development

Table 67. Nippon Shinyaku Company Details

Table 68. Nippon Shinyaku Business Overview

Table 69. Nippon Shinyaku Small Nucleic Acid Drug Product

Table 70. Nippon Shinyaku Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 71. Nippon Shinyaku Recent Development

Table 72. Sobi Company Details

Table 73. Sobi Business Overview

Table 74. Sobi Small Nucleic Acid Drug Product

Table 75. Sobi Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 76. Sobi Recent Development

Table 77. Novartis Company Details

Table 78. Novartis Business Overview

Table 79. Novartis Small Nucleic Acid Drug Product

Table 80. Novartis Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 81. Novartis Recent Development

Table 82. Jazz Pharmaceuticals Company Details

Table 83. Jazz Pharmaceuticals Business Overview

Table 84. Jazz Pharmaceuticals Small Nucleic Acid Drug Product

Table 85. Jazz Pharmaceuticals Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 86. Jazz Pharmaceuticals Recent Development

Table 87. AstraZeneca Company Details

Table 88. AstraZeneca Business Overview

Table 89. AstraZeneca Small Nucleic Acid Drug Product

Table 90. AstraZeneca Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 91. AstraZeneca Recent Development

Table 92. Novo Nordisk Company Details

Table 93. Novo Nordisk Business Overview

Table 94. Novo Nordisk Small Nucleic Acid Drug Product

Table 95. Novo Nordisk Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 96. Novo Nordisk Recent Development

Table 97. Astellas Pharma Company Details

Table 98. Astellas Pharma Business Overview

Table 99. Astellas Pharma Small Nucleic Acid Drug Product

Table 100. Astellas Pharma Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 101. Astellas Pharma Recent Development

Table 102. Geron Corporation Company Details

Table 103. Geron Corporation Business Overview

Table 104. Geron Corporation Small Nucleic Acid Drug Product

Table 105. Geron Corporation Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 106. Geron Corporation Recent Development

Table 107. CureVac Company Details

Table 108. CureVac Business Overview

Table 109. CureVac Small Nucleic Acid Drug Product

Table 110. CureVac Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 111. CureVac Recent Development

Table 112. Regulus Therapeutics Company Details

Table 113. Regulus Therapeutics Business Overview

Table 114. Regulus Therapeutics Small Nucleic Acid Drug Product

Table 115. Regulus Therapeutics Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 116. Regulus Therapeutics Recent Development

Table 117. ProQR Company Details

Table 118. ProQR Business Overview

Table 119. ProQR Small Nucleic Acid Drug Product

Table 120. ProQR Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 121. ProQR Recent Development

Table 122. Secarna Company Details

Table 123. Secarna Business Overview

Table 124. Secarna Small Nucleic Acid Drug Product

Table 125. Secarna Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 126. Secarna Recent Development

Table 127. MiNA Therapeutics Company Details

Table 128. MiNA Therapeutics Business Overview

Table 129. MiNA Therapeutics Small Nucleic Acid Drug Product

Table 130. MiNA Therapeutics Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 131. MiNA Therapeutics Recent Development

Table 132. Sylentis Company Details

Table 133. Sylentis Business Overview

Table 134. Sylentis Small Nucleic Acid Drug Product

Table 135. Sylentis Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 136. Sylentis Recent Development

Table 137. Arrowhead Company Details

Table 138. Arrowhead Business Overview

Table 139. Arrowhead Small Nucleic Acid Drug Product

Table 140. Arrowhead Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 141. Arrowhead Recent Development

Table 142. Silence Therapeutics Company Details

Table 143. Silence Therapeutics Business Overview

Table 144. Silence Therapeutics Small Nucleic Acid Drug Product

Table 145. Silence Therapeutics Revenue in Small Nucleic Acid Drug Business (2020-2025) & (US$ Million)

Table 146. Silence Therapeutics Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

Table 150. Authors List of This Report

List of Figures

Figure 1. Small Nucleic Acid Drug Picture

Figure 2. Global Small Nucleic Acid Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Small Nucleic Acid Drug Market Share by Type: 2024 VS 2031

Figure 4. Antisense Oligonucleotides (ASO) Features

Figure 5. siRNA Features

Figure 6. Other Features

Figure 7. Global Small Nucleic Acid Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Small Nucleic Acid Drug Market Share by Application: 2024 VS 2031

Figure 9. Neuromuscular Diseases Case Studies

Figure 10. hATTR Case Studies

Figure 11. Other Case Studies

Figure 12. Small Nucleic Acid Drug Report Years Considered

Figure 13. Global Small Nucleic Acid Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Small Nucleic Acid Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Small Nucleic Acid Drug Market Share by Region: 2024 VS 2031

Figure 16. Global Small Nucleic Acid Drug Market Share by Players in 2024

Figure 17. Global Top Small Nucleic Acid Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Nucleic Acid Drug as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Small Nucleic Acid Drug Revenue in 2024

Figure 19. North America Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Small Nucleic Acid Drug Market Share by Country (2020-2031)

Figure 21. United States Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Small Nucleic Acid Drug Market Share by Country (2020-2031)

Figure 25. Germany Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Small Nucleic Acid Drug Market Share by Region (2020-2031)

Figure 33. China Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Small Nucleic Acid Drug Market Share by Country (2020-2031)

Figure 41. Mexico Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Small Nucleic Acid Drug Market Share by Country (2020-2031)

Figure 45. Turkey Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Small Nucleic Acid Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Sarepta Therapeutics Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 49. Ionis Pharmaceuticals Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 50. Alnylam Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 51. Biogen Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 52. Nippon Shinyaku Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 53. Sobi Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 55. Jazz Pharmaceuticals Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 56. AstraZeneca Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 57. Novo Nordisk Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 58. Astellas Pharma Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 59. Geron Corporation Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 60. CureVac Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 61. Regulus Therapeutics Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 62. ProQR Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 63. Secarna Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 64. MiNA Therapeutics Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 65. Sylentis Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 66. Arrowhead Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 67. Silence Therapeutics Revenue Growth Rate in Small Nucleic Acid Drug Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nucleic Acid Medicine Market Research Report 2025

Global Small Interfering RNA siRNA Drugs Market Research Report 2024

Global Small Interfering RNA siRNA based Therapeutics Market Research Report 2024

Global RNA Interference RNAi Based Therapeutics Market Research Report 2024

Global RNA based Therapeutics Drug Market Research Report 2024

Global Nucleic acid based Therapeutics Drug Market Research Report 2024

Global Nucleic Acid Therapeutic Market Research Report 2024

Global Nucleic Acid based Therapy Market Research Report 2024

Global Low Molecular Weight Nucleic Acid Drugs Market Research Report 2025

Global Small Nucleic Acid Based Drug Market Research Report 2025

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Drugs ONs Market Research Report 2025

Global Nucleic Acid Aptamers Market Research Report 2025

Global ASO based Drug Market Research Report 2024

Small Molecule Nucleic Acid Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global miRNA Drug Market Research Report 2024

Global Antisense Oligonucleotides ASO Drug Market Research Report 2024

Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions